In Re: Zoloft Products Liability Litigation

E-Law Admin/ Juni 2, 2017/ Arzneimittelrecht Schweiz/ 0Kommentare

In Re: Zoloft Products Liability Litigation, 16-2247

In multi-district litigation involving allegations that the anti-depressant drug Zoloft, manufactured by Pfizer, causes cardiac birth defects when taken during early pregnancy, the district court’s orders excluding plaintiffs’ expert testimony which used the ‘Bradford Hill’ criteria to analyze existing literature on the causal connection between Zoloft and birth defects, are affirmed where the District Court: 1) did not establish a legal standard that an expert opinion on general causation must be supported by replicated observational studies reporting a statistically significant association between the drug and the adverse effect; and 2) did not abuse its discretion in excluding the expert’s testimony.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/06/02



  • United States Third Circuit


e-Law Trainer

Share this Post

Hinterlasse einen Kommentar